These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [J-ELAN study (effect of losartan and amlodipine on left ventricular diastolic function in patients with mild-to-moderate hypertension)]. Yamamoto K; Hori M Nihon Rinsho; 2007 Apr; 65 Suppl 4():513-5. PubMed ID: 17511101 [No Abstract] [Full Text] [Related]
3. The antihypertensive efficacy of losartan and amlodipine assessed with office and ambulatory blood pressure monitoring. Canadian Cozaar Hyzaar Amlodipine Trial Study Group. Wilson TW; Lacourcière Y; Barnes CC CMAJ; 1998 Sep; 159(5):469-76. PubMed ID: 9757170 [TBL] [Abstract][Full Text] [Related]
4. Control of home blood pressure with an amlodipine- or losartan-based regimen and progression of carotid artery intima-media thickness in hypertensive patients: the HOSP substudy. Ohta Y; Kawano Y; Iwashima Y; Hayashi S; Yoshihara F; Matayoshi T; Takiuchi S; Kamide K; Nakamura S; Horio T Clin Exp Hypertens; 2013; 35(4):279-84. PubMed ID: 23530977 [TBL] [Abstract][Full Text] [Related]
11. Interim evidence of the renoprotective effect of the angiotensin II receptor antagonist losartan versus the calcium channel blocker amlodipine in patients with chronic kidney disease and hypertension: a report of the Japanese Losartan Therapy Intended for Global Renal Protection in Hypertensive Patients (JLIGHT) Study. Iino Y; Hayashi M; Kawamura T; Shiigai T; Tomino Y; Yamada K; Kitajima T; Ideura T; Koyama A; Sugisaki T; Suzuki H; Umemura S; Kawaguchi Y; Uchida S; Kuwahara M; Yamazaki T; Clin Exp Nephrol; 2003 Sep; 7(3):221-30. PubMed ID: 14586719 [TBL] [Abstract][Full Text] [Related]
12. Role of plasma aldosterone concentration in regression of left-ventricular mass following antihypertensive medication. Yoshida C; Goda A; Naito Y; Nakaboh A; Matsumoto M; Otsuka M; Ohyanagi M; Hirotani S; Lee-Kawabata M; Tsujino T; Masuyama T J Hypertens; 2011 Feb; 29(2):357-63. PubMed ID: 21052021 [TBL] [Abstract][Full Text] [Related]
13. [Pharmacogenetics of angiotensin system in non diabetic nephropathy]. Coto E; Marín R; Alvarez V; Praga M; Fernández Andrade C; Arias M; Poveda R; Vallés M; Galcerán JM; Luño J; Rivera F; Campistol JM Nefrologia; 2005; 25(4):381-6. PubMed ID: 16231503 [TBL] [Abstract][Full Text] [Related]
15. Blood pressure and medication during long-term antihypertensive therapy based on morning home SBP in hypertensive patients: Hypertension Control Based on Home Systolic Pressure (HOSP) substudy. Kawano Y; Horio T; Kamide K; Iwashima Y; Yoshihara F; Nakamura S Clin Exp Hypertens; 2010 Jul; 32(4):239-43. PubMed ID: 20608895 [TBL] [Abstract][Full Text] [Related]
16. Two amlodipine/ARB combinations for hypertension. Med Lett Drugs Ther; 2007 Dec; 49(1276):101-2. PubMed ID: 18084152 [No Abstract] [Full Text] [Related]
17. [Treatment of hypertension in elderly patients with coronary heart disease]. Iwai K; Morimoto S; Matsumoto M Nihon Rinsho; 2005 Jun; 63(6):1033-9. PubMed ID: 15948387 [TBL] [Abstract][Full Text] [Related]
18. Rationale, design and patient baseline characteristics of OlmeSartan and calcium antagonists randomized (OSCAR) study: a study comparing the incidence of cardiovascular events between high-dose angiotensin II receptor blocker (ARB) monotherapy and combination therapy of ARB with calcium channel blocker in Japanese elderly high-risk hypertensive patients (ClinicalTrials. gov no. NCT00134160). Ogawa H; Kim-Mitsuyama S; Jinnouchi T; Matsui K; Arakawa K Hypertens Res; 2009 Jul; 32(7):575-80. PubMed ID: 19444280 [TBL] [Abstract][Full Text] [Related]
19. Prospective and randomized study of the antihypertensive effect and tolerability of three antihypertensive agents, losartan, amlodipine, and lisinopril, in hypertensive patients. Wu SC; Liu CP; Chiang HT; Lin SL Heart Vessels; 2004 Jan; 19(1):13-8. PubMed ID: 14685749 [TBL] [Abstract][Full Text] [Related]
20. Amlodipine/valsartan single-pill combination: a review of its use in the management of hypertension. Frampton JE; Scott LJ Am J Cardiovasc Drugs; 2009; 9(5):309-30. PubMed ID: 19791840 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]